QUANTRX BIOMEDICAL CORP Quarterly Preferred Stock, Shares Authorized from Q4 2011 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Quantrx Biomedical Corp quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2011 to Q3 2022.
  • Quantrx Biomedical Corp Preferred Stock, Shares Authorized for the quarter ending September 30, 2022 was 25M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 25M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 25M 0 0% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 25M 0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 25M 0 0% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 25M 0 0% Sep 30, 2021 10-Q 2021-11-16
Q2 2021 25M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 25M 0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 25M 0 0% Dec 31, 2020 10-K 2022-04-15
Q3 2020 25M 0 0% Sep 30, 2020 10-Q 2020-11-17
Q2 2020 25M 0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 25M 0 0% Mar 31, 2020 10-Q 2020-05-20
Q4 2019 25M 0 0% Dec 31, 2019 10-K 2021-04-15
Q3 2019 25M 0 0% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 25M 0 0% Jun 30, 2019 10-Q 2019-08-15
Q1 2019 25M 0 0% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 25M 0 0% Dec 31, 2018 10-K 2020-04-14
Q3 2018 25M 0 0% Sep 30, 2018 10-Q 2018-11-19
Q2 2018 25M 0 0% Jun 30, 2018 10-Q 2018-08-20
Q1 2018 25M 0 0% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 25M 0 0% Dec 31, 2017 10-K 2019-04-16
Q3 2017 25M 0 0% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 25M 0 0% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 25M 0 0% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 25M 0 0% Dec 31, 2016 10-K 2018-04-17
Q3 2016 25M 0 0% Sep 30, 2016 10-Q 2016-12-02
Q2 2016 25M 0 0% Jun 30, 2016 10-Q 2016-08-17
Q1 2016 25M 0 0% Mar 31, 2016 10-Q 2016-05-20
Q4 2015 25M 0 0% Dec 31, 2015 10-K 2017-04-17
Q3 2015 25M +4.5M +22% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 25M +4.5M +22% Jun 30, 2015 10-Q 2015-08-17
Q1 2015 25M 0 0% Mar 31, 2015 10-Q 2015-07-22
Q4 2014 25M +4.5M +22% Dec 31, 2014 10-K 2016-04-13
Q3 2014 20.5M -4.5M -18% Sep 30, 2014 10-Q 2014-11-18
Q2 2014 20.5M -4.5M -18% Jun 30, 2014 10-Q 2014-08-19
Q1 2014 25M 0 0% Mar 31, 2014 10-Q/A 2014-05-23
Q4 2013 20.5M 0 0% Dec 31, 2013 10-Q 2014-11-18
Q3 2013 25M 0 0% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 25M +4.5M +22% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 25M +4.5M +22% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 20.5M 0 0% Dec 31, 2012 10-Q 2013-11-19
Q3 2012 25M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 20.5M Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 20.5M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 20.5M Dec 31, 2011 10-K 2013-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.